Manufacturing

Raw material imports for medicine currently account for $749 million in annual spending, representing more than half of the country's total medicinal foreign-exchange costs. This financial burden has catalyzed a strategic pivot toward domestic biotechnology, as the nation seeks to insulate its

In the vast, scorched expanse of the Algerian hamada, where the horizon is often obscured by swirling silts and the sun beats down with unforgiving intensity, an unlikely beacon of scientific progress has taken root. The laboratory manages a consistent catalog of 15 to 20 different medications,

Supply chain functions in the life sciences sector frequently lag behind other departments because sustainability data is not yet integrated into daily financial decision-making. Impact Stewards, a leading healthcare consultancy, has addressed this critical gap by launching the Sustainable Supply

The core architecture of a chimeric antigen receptor relies on a single-chain variable fragment linked to intracellular signaling components that ignite T cell proliferation. As the pharmaceutical industry entered the second half of the current decade, the shift from experimental novelty to

Singapore’s integration into European testing networks ensures that biological drugs manufactured in the city-state meet the world's most stringent laboratory standards. This development signifies a broader shift in the city-state's role, transitioning from a localized regulatory body into a

Researchers at Birjand University of Medical Sciences are targeting the unique mechanical requirements of the knee by leveraging the dense native collagen found in camels. This specific focus on camel-derived tissue addresses one of the most persistent challenges in orthopedic medicine: the repair